We will be able to customize the approach to make sure your specific goals are reflected in the treatment plan
Patients Ready to Follow a Treatment Plan Candidates should be willing to follow provider recommendations, administration instructions and scheduled follow-up care
Lets break down the science, set realistic timelines, and clear the confusion between expectation and realitywith honest insights from Dr
Filip Krag Knop has served on scientific advisory panels and/or been part of speakers bureaus for, served as a consultant to, and/or received research support from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Carmot Therapeutics, Eli Lilly, Gubra, MedImmune, MSD/Merck, Mundipharma, Norgine, Novo Nordisk, Sanofi, and Zealand Pharma
Similar to the other once-weekly products, Ozempic is a GLP-1 RA